Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn't eliminate that pressure. It did, however, pursue voluntary pricing agreements with many of the industry's largest drugmakers. Since late…
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion. Index…
OneSource Specialty Pharma ties up with Germany's Formycon for Biosimilar manufacturing
OneSource Specialty Pharma Limited announced a strategic manufacturing partnership with Formycon AG, a Munich-based independent biosimilar developer, today. Under the agreement, OneSource will provide integrated Drug Substance and Drug Product…
Natco Pharma raises Adcock Ingram stake to 49%, pays ₹1,060 crore
Hyderabad-based Natco Pharma Limited on Tuesday completed the acquisition of an additional 13.25 per cent equity stake in South African pharmaceutical company Adcock Ingram Holdings Proprietary Limited, bringing its total shareholding to 49 per…
Q3 Earnings Estimate for OKYO Pharma Issued By HC Wainwright
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Free Report) - Investment analysts at HC Wainwright issued their Q3 2027 earnings estimates for OKYO Pharma in a research report issued to clients and investors on Monday, July 13th. HC Wainwright…
Athira Pharma (NASDAQ:LONA) Trading Up 13% - Should You Buy?
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) shares were up 13% during trading on Monday. The company traded as high as $9.39 and last traded at $9.7950. Approximately 4,884 shares were traded during mid-day trading, a decline of 77% from…
Canal Insurance CO Acquires Shares of 20,000 Royalty Pharma PLC $RPRX
Canal Insurance CO acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 20,000 shares…
Emerald Advisers LLC Sells 20,403 Shares of BridgeBio Pharma, Inc. $BBIO
Emerald Advisers LLC lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 3.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund…
13,665 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC bought a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 13,665 shares of the company's…
Calamos Wealth Management LLC Acquires New Shares in Royalty Pharma PLC $RPRX
Calamos Wealth Management LLC bought a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought…
Pictet Asset Management Holding SA Lowers Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Pictet Asset Management Holding SA lessened its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 99.1% during the first quarter, according to the company in its most recent filing with the Securities and…
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
Eli Lilly (LLY 0.09%) and Novo Nordisk (NVO 0.35%) today participate in one of the most exciting growth markets in healthcare: the weight loss drug market, one that's on track to reach nearly $100 billion in a few years. Novo was the first to…
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo…
Sensex drops 561 points over West Asia flare-up
Stock market benchmark indices Sensex and Nifty tumbled on Tuesday as a sharp surge in crude oil prices due to the renewed flare-up in West Asia dented investors' sentiment. Fresh foreign fund outflows and the falling rupee also put pressure on the…
Nifty Prediction Today - July 14, 2026: Nifty futures: Stays in a range but exhibits bearish tilt
Nifty 50 began today's session with a gap-down at 24,068 versus Monday's close of 24,211. It is now trading at 24,090, down 0.5 per cent. The advance/decline ratio stands at 18/32, showing a bearish bias. Cipla and Bharti Airtel (up 1.3 per cent…
Receive a Daily briefing on Pharma Industry News
Get Started